Table 1 clinical data of GBM patients’ from which tumors were obtained for cell line establishment
Tumor case/cell line | Age/ Gender | Diagnosis/ Tumor location | MGMT promoter methylation status Molecular characteristics |
|---|---|---|---|
HROG02 | 69/m | GBM WHO °4/ right-sided parietooccipital | Methylated |
HROG05 | 56/f | GBM WHO °4/ left-sided temporal lobe | Methylated KrasG12D |
HROG63 | 47/m | GBM WHO °4/ left-sided temporal lobe | Unmethylated |
GBM03 | 81/m | GBM WHO °4/ right-sided temporal lobe | Unmethylated |
GBM06 | 71/m | GBM WHO °4/ temporal lobe | − |
GBM14 | 63/m | GBM WHO °4/ left-sided temporal lobe | Unmethylated |
GBM15 | 40/m | GBM WHO °4/ left-sided temporal lobe | Unmethylated |